Clinical Trial Update: (2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of (2R,6R)-Hydroxynorketamine for neuropathic pain, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• (2R,6R)-Hydroxynorketamine (Hydroxynorketamine)

Snippet

Sponsor: Rush University Medical Center | Conditions: Pain, Neuropathic | Phase 1, Phase 2 | Status: RECRUITING